Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/28/2025

Oral Minoxidil Safety for Men Trying to Conceive

Evidence Assessment

  • The European Urology guidelines state that current clinical guidelines on male infertility do not specifically address oral minoxidil use in men attempting conception, highlighting the need for comprehensive fertility evaluation 1, 2
  • The European Urology guidelines recommend that men should undergo medical and reproductive history, physical examination, and semen analysis before and during treatment 1, 2

Clinical Context

  • The European Urology guidelines emphasize that modifiable factors like smoking cessation, weight loss, and physical exercise should be addressed first, as these have proven benefits for sperm parameters 2
  • Men experiencing fertility issues should disclose all medication use, including oral minoxidil, to their healthcare providers during fertility evaluations, as recommended by the Praxis Medical Insights 3

Practical Recommendations

  • The European Urology guidelines recommend obtaining baseline semen analysis before starting oral minoxidil treatment and repeating if abnormalities develop 1
  • If conception has not occurred after 12 months of regular unprotected intercourse, both partners should undergo evaluation regardless of medication use, as recommended by the European Urology guidelines 1

Monitoring Protocol

  • The European Urology guidelines recommend obtaining baseline semen analysis before oral minoxidil treatment initiation, repeating semen analysis if conception does not occur within 6 months, and discontinuing the medication if semen parameters deteriorate significantly 1, 2